IDEXX LABORATORIES INC (IX1.DE) Stock Balance Sheet
Europe - Frankfurt Stock Exchange - FRA:IX1 - US45168D1046 - Common Stock
612.6 EUR
+30.2 (+5.19%)
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 308.64M | 453.93M | 112.50M | 144.50M | 383.90M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 587.07M | 529.53M | 490.90M | 425.60M | 374.70M | |||
| Inventories | 389.80M | 380.28M | 367.80M | 269.00M | 209.90M | |||
| Other Current Assets | 148.23M | 131.51M | 130.20M | 116.60M | 94.20M | |||
| Total Current Assets | 1.43B | 1.50B | 1.10B | 955.70M | 1.06B | |||
| Non-Current Assets | ||||||||
| PPE Net | 838.80M | 817.68M | 768.10M | 692.80M | 646.30M | |||
| Investments And Advances | 55.23M | 56.19M | 55.50M | 18.60M | 12.10M | |||
| Goodwill | 412.07M | 365.96M | 361.80M | 359.30M | 243.30M | |||
| Intangibles | 106.89M | 84.50M | 97.70M | 99.00M | 52.50M | |||
| Other Non-Current Assets | 318.18M | 272.38M | 212.50M | 187.80M | 179.50M | |||
| Total Non-Current Assets | 1.92B | 1.76B | 1.65B | 1.48B | 1.23B | |||
| TOTAL ASSETS | 3.35B | 3.26B | 2.75B | 2.44B | 2.29B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 250.00M | 250.00M | 579.00M | 73.50M | 0.00 | |||
| Current Portion Of LT Debt. | 99.14M | 75.00M | 75.00M | 75.00M | 50.00M | |||
| Accrued Expenses | 430.97M | 392.16M | 385.10M | 416.30M | 373.00M | |||
| Accounts Payable | 110.60M | 110.64M | 110.20M | 116.10M | 74.60M | |||
| Other Current Liabilities | 118.51M | 123.75M | 86.50M | 82.60M | 85.20M | |||
| Total Current Liabilities | 1.01B | 951.55M | 1.24B | 763.60M | 582.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 524.76M | 622.88M | 694.40M | 775.20M | 858.50M | |||
| Deferred Taxes/Income | 5.66M | 7.24M | 8.20M | 8.90M | 11.70M | |||
| Other Non-Current Liabilities | 193.07M | 193.73M | 199.70M | 199.50M | 208.80M | |||
| Total Non-Current Liabilities | 723.49M | 823.85M | 902.20M | 983.60M | 1.08B | |||
| TOTAL LIABILITIES | 1.73B | 1.78B | 2.14B | 1.75B | 1.66B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 5.12B | 4.44B | 3.60B | 2.92B | 2.18B | |||
| Additional Paid In Capital | 1.65B | 1.57B | 1.46B | 1.38B | 1.29B | |||
| Minority Interest | N/A | N/A | N/A | 0.00 | 700.00K | |||
| Common Shares | 16.66M | 16.28M | 15.90M | 16.40M | 15.10M | |||
| Treasury Stock | -5.09B | -4.47B | -4.39B | -3.57B | -2.80B | |||
| Other Shareholders' Equity | -75.97M | -71.04M | -77.60M | -53.40M | -53.30M | |||
| Shares Outstanding | 82.04M | 83.03M | 82.90M | 84.60M | 85.40M | |||
| Tangible Book Value per Share | 13.40 | 12.45 | 1.80 | 2.74 | 3.94 | |||
| Total Shareholders' Equity | 1.62B | 1.48B | 608.70M | 690.00M | 632.10M | |||
| TOTAL LIABILITIES AND EQUITY | 3.35B | 3.26B | 2.75B | 2.44B | 2.29B | |||
| Statistics | ||||||||
| Debt/Equity | 0.48 | 0.59 | 2.09 | 1.23 | 1.36 | |||
| Current Ratio | 1.42 | 1.57 | 0.89 | 1.25 | 1.82 | |||
| Return On Assets (ROA) | 25.85% | 25.92% | 24.72% | 30.56% | 25.36% | |||
| Return On Equity (ROE) | 53.54% | 56.92% | 111.57% | 107.94% | 92.04% | |||
| Return On Invested Capital (ROIC) | 34.02% | 34.04% | 34.23% | 42.40% | 32.20% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 38.62% | 41.38% | 36.18% | 46.22% | 41.51% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 49.99% | 52.65% | 47.13% | 64.73% | 53.41% | |||
All data in USD , ROIC based on taxRate of 0.21